, Tracking Stock Market Picks
Enter Symbol:
CVS Corporation (CVS) [hlAlert]

up 114.16 %

CVS Corporation (CVS) rated Overweight with price target $110 by Barclays

Posted on: Friday,  Dec 18, 2015  2:25 PM ET by Barclays

Barclays rated Overweight CVS Corporation (NYSE: CVS) on 12/18/2015. Previously Barclays rated Overweight CVS Corporation (NYSE: CVS) on 12/17/2012., when
the stock price was $49.12. Since then, CVS Corporation has gained 114.17% as of 01/22/2016's recent price of $105.20.
If you would have followed the previous Barclays's recommendation on CVS, you would have gained 114.16% of your investment in 1131 days.

CVS Caremark Corporation (CVS Caremark) is a provider of prescriptions and related healthcare services in the United States. It is a pharmacy services company and drives value for its customers through its approximately 6,900 CVS/pharmacy and Longs Drug retail stores; CVS Caremark?s pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; its retail-based health clinic subsidiary, MinuteClinic, and Its online pharmacy, The Company operates in two business segments: Pharmacy Services and Retail Pharmacy. October 20, 2008, CVS Caremark acquired Longs Drug Stores Corporation, which includes 529 retail drug stores (the Longs Drug Stores) and RxAmerica LLC (RxAmerica), which provides pharmacy benefit management services, and certain other related assets.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/18/2015 2:25 PM Buy
95.27 110.00
as of 8/27/2015
1 Week down  -0.77 %
1 Month down  -1.19 %
3 Months up  3.17 %
1 YTD up  46.98 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/5/2014 12:00 AM Buy
74.98 85.00
5/2/2013 1:25 PM Buy
58.78 67.00
12/17/2012 1:25 PM Buy
49.12 57.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy